New and Emerging Cancer Treatments Flashcards

1
Q

Need for targeted therapies

A
  • Traditional chemotherapies = number of SFx
  • Ways to maximise localised delivery of drugs are therefore required
  • Some cancers don’t have effective clinical regimens; e.g. advanced, metastatic cancers, those that have developed resistance
  • Need more targeted treatments

DONT MEMORISE JSUT READ OVER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prodrugs

A
  • Derivative of an active drug that has no intrinsic activity
  • Converted to the active drug in vivo at the appropriate time or place
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are prodrugs activated?

A
  • over-expression of a specific enzyme that activates the prodrug
  • modification of the target cell to express the enzyme required for the drug release.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does ‘ADEPT’ refer to?

A

Antibody-directed enzyme prodrug

(1) Design of an mAb developed against a tumour associated antigen
(2) Antibody-enzyme complex generated and administered
(3) Specificity of the antibody for the antigen allows the antibody-enzyme conjugate to be selectively delivered to the tumour cells.
(4) Prodrug administered
(5) Once enzyme is bound to tumour cell –> prodrug activated = kill tumour cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some advantages of ADEPT?

A
  • Reduced systemic toxicity
  • Opportunity to overcome drug resistance
  • Opportunity to revisit drugs that have shown excellent profiles in vitro, or in early clinical trials, but that have not been pursued due to toxicity profiles.
  • Amplification of the drug effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some challenges of ADEPT?

A
  • immune responses to antibody-enzyme complexes
  • identification of appropriate cancer antigen targets
  • cost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does ‘GDEPT’ refer to?

A

Gene-Directed Enzyme Prodrug Therapy
- Mirrors ADEPT but gene therapy
- Introduction of a gene into the tumor cells that produces an enzyme specific to tumour cells
- Prodrugs are administered and activated same as ADEPT
- + and - (see ADEPT)
- No GDEPT product currently marketed as a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does ‘PDEPT’ refer to?

A
  • Polymer-Directed Enzyme Prodrug Therapy
    1. Polymeric prodrug + polymer-enzyme conjugate administered
    2. Both localise in the tumour due to EPR effect
    3. Enzyme which activates the drug is delivered separately to the tumour
    4. Pro drug activated
    3. Generate cytotoxic drug selectively at the tumour site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does ‘MDEPT’ refer to?

A

Melanocyte-Directed Enzyme Prodrug Therapy
- Malignant melanoma; most serious form of skin cancer as metastasis can occur early and it causes a number of deaths even in young people.
- Metastasis: target the lung, liver and colon.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ABCDE

A

General guideline for symptoms of melanoma
1. Assymmetrical
2. Border
3. Colour
4. Diameter
5. Elevation and enlargement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Breslow Thickness Scale

A

Scale used to classify the thickness of the tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clark’s Level

A

Scale used to classify the depth of the tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Targeted therapy - Carbohydrate Biosynthesis

A
  • Carbohydrates are synthesised in nature by a series of enzymes
  • In some cases the balance and activity of enzymes required for carbohydrate synthesis is disrupted
  • Unusual carbs are synthesised and generated on the cell surface
  • Confers unusual and often undesirable properties to the cell
  • Believed that such processes are responsible for cancer metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does cancer metastasis occur due to carbohydrate bioynthesis?

A
  • By allowing cell surface carbohydrates to interact with lectins in blood vessels
  • Alowing migration of the tumour from one site to another
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Chemical modification of biopolymers in vivo

A
  • Utilise the biosynthetic production of sialic acid on cancer cells for targeted treatment
  • Through ‘biochemical engineering’.
  • Uses the enzymatic machinery of cells to achieve chemical synthesis of novel biomolecules in the cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Benefits of engineered biomolecules

A
  • May have novel properties
  • Provide insight into the importance of certain molecules/functional groups in biological processes
  • Provided useful tooks in: Drug discovery, delivery, gene therapy, bioseparation or diagnostics
17
Q

Biosynthesis of Sialic Acid

A
  1. ketone groups introduced onto cell surface of molecules.
  2. Selective reaction of those cells with nitrogen nucleophiles such as aminooxy- or hydrazidefunctional molecules
  3. Permits covalent attachment of a wide range of structures to the cancer cell surface
  4. Under physiological conditions
  5. This offers the possibility to bind drugs, dyes or magentic resonance imaging reagents selectively to the cancer cells
18
Q

Impact of modified sialic acid biosynthesis

A
  • Chemicall remodelling of cell surfaces in living animals.
  • Immunotargeting of tumour cells by creating vaccines based on cancer specific cell
  • Surface glycoconjugate antigens has long been proposed, but many tumour cells dail to express unique markers
19
Q

Sialic acid and ManNProp

A
  • ManNProp: a modified derivative of a precursor to sialic acid
  • Can use it to generate carbohydrates on tumour surfaces that contain modified sialic acid, specifically N-propionylneuraminic acid.
  • MAbs available for this, allow antibody-mediated cell killing.
  • In an in vivo study this antibody effectively controlled metastasis of solid tumour model in mice which had been given ManNProp